Zantac Cancer Lawsuit
Attorneys Reviewing Cases for Zantac Class Action Lawsuit Rosenfeld Injury Lawyers LLC is reviewing cases for joining a class-action Zantac lawsuit related to the cancer risk in patients who have taken the popular heartburn medication drug Zantac products (active ingredient Ranitidine) for heartburn, peptic ulcers, and gastroesophageal reflux disease (GERD).
NDMA Contamination in Zantac (Ranitidine) Associated With CancerThe Zantac recall lawyers in our office are currently reviewing cases from people who have developed cancer after taking Zantac contaminated with high levels of NDMA (N-nitrosodimethylamine), a probable human carcinogen.
All of our Zantac cancer lawsuits are handled on a contingency fee basis, where there is only a legal fee charged when we are successful in obtaining a financial recovery for you.
We invite you to contact us any time to discuss your case with our Zantac lawyers for a free case evaluation.
Our personal injury attorneys have extensive experience handling lawsuits involving dangerous drugs and recalled medications against drug manufacturers.
Our trial lawyers are reviewing cases involving consumer exposure to unacceptable levels of NDMA in heartburn medication and who have developed cancer after taking Zantac ranitidine products from across the country.
Food and Drug Administration Warns of Cancer Risk With ZantacZantac is amongst the most popular and widely used over-the-counter medications for the relief of heartburn and gastroesophageal reflux disease.
Zantac belongs to the class of drugs known as H2 blockers, which decrease acid levels in the stomach.
In September 2019, the U.S. Food and Drug Administration (FDA) issued a warning to consumers and healthcare professionals that laboratory tests revealed some ranitidine products to be contaminated with high levels of the suspected carcinogen called N-Nitrosodimethylamine NDMA, which is believed to be associated with an increased risk of certain type of cancer.
The agency has since declared the NDMA levels found in these products to be “unacceptably high.”
Exposure to significant amounts of NDMA can cause cancer in the liver, gastrointestinal tract, stomach and colon and is known to seriously damage the liver according to FDA reports.
FDA Issues Recall of Ranitidine and Zantac Due to 'Unacceptable Levels' of NDMA
After much debate, on April 1, 2020, the U.S. FDA (Food and Drug Administration) has ordered all Zantac and ranitidine medications (ranitidine tablets) to be immediately recalled from store shelves as well as online pharmacies.
This governmental recall comes after several Zantac and ranitidine manufacturers voluntarily issued recalls and national pharmacy chains CVS, Walgreens, Valisure, Walmart and Rite-Aid pulled all ranitidine-containing products including Zantac from their shelves.
Several countries including Canada and France have officially recalled the drugs due to the presence of NDMA.
This move follows the World Health Organization announcement that NDMA is a cancer causing chemical.
Science Connecting Zantac With Production of NDMAWhile we anticipate learning more about the connection between Zantac use and cancer from the various manufacturers as pending Zantac lawsuits move through the discovery phases of litigation, we do know the following in terms of the correlation between the ingestion of Zantac and the bodies production of NDMA.
The science strongly supports that Zantac causes cancer.
National Cancer Institute: In 2004 the Center published a study that linked antacids and ranitidine to the development of bladder cancer.
Pottegard Study: This study examined men and women who took 150 mg tablets of ranitidine and examined their urine composition 24 hours before and after use. The study found NDMA levels in urine to be 47,600 ng /person. The equivalent of nearly 500 times higher than the FDA's acceptable dose level.
Valisure: This pharmaceutical research company found an enzyme in the body that manufactures high levels of NDMA. The findings were concerning enough that they brought their findings to the attention of the FDA in September, 2019.
Emery Pharma: In January, 2020 the company filed a petition with the FDA finding that high levels of NDMA developed when ranitidine was exposed to heat (higher than room temperatures).
Zantac (Randitine) Cancer Lawsuit FAQs
If you or a loved one has taken Zantac or ranitidine or another heartburn drug, you are likely alarmed and confused by these developments and reports of adverse events by the FDA. In this article we will try to address some of your concerns:
- What is NDMA?
- Has Zantac been recalled and what should I do if I currently take it?
- What are the medical complications associated with NDMA?
- Should I stop taking Zantac?
- Have any lawsuits been filed against the manufacturer of Zantac?
- What compensation can a person who was harmed by Zantac recover in a lawsuit?
Contact Our Zantac Lawsuit Law Firm if You Have Been Exposed to NDMA
If you are currently taking Zantac you should speak to your health care provider right away.
If you have taken a form of ranitidine medications and developed a form of cancer in the liver or digestive tract, you should consider taking immediate legal action against the pharmaceutical companies and distributors who manufactured, marketed, and sold the defective drug as you may be entitled to compensation.
Time is of the essence because there are statutes of limitations that apply to file claims against Zantac's manufacturer at both the federal and state court levels.
The drug recall attorneys at Rosenfeld Injury Lawyers LLC are monitoring potential Zantac class action lawsuits across the United States.
Our office is centrally located in Chicago, Illinois, and we have extensive experience with drug recalls and pending multi-district litigation (MDL) and class action lawsuits involving serious injuries.
We invite you to discuss your experience and your legal options related to the Zantac recall with us at no cost or obligation.
If you've been diagnosed with cancer, you may be eligible to join the class action Zantac lawsuit.
What is NDMA?
The organic compound, formerly used to make rocket fuel, is known to cause cancer in research animals. NDMA is described as a waste product of industrial processes including the making of industrial lubricants and pesticides. It is part of the N-nitrosamine family of potent carcinogens.
The yellowish, odorless liquid is said to be present at supposedly safe micro levels in some food products—particularly cured meats—and water supplies, even beer.
The toxic chemical has been found to damage the liver and other organs in humans. The U.S. Environmental Protection Agency (EPA) has concluded that NDMA is a “probable human carcinogen” that can increase a person’s risk of developing cancer.
Although most of what is currently known about NDMA’s carcinogenic qualities come from animal-based studies, the World Health Organization has reported that several case-control studies and one cohort study of dietary intake of high does of NDMA in the human body showed results “supportive of the assumption that NDMA consumption is a probable carcinogen is positively associated with either gastric or colorectal cancer.”
The main issue in current Zantac and ranitidine medicines cases centers around the contamination of NDMA into the products during a chemical reaction in the manufacturing process.
At this time, medical professionals believe the NDMA in Zantac is responsible for the thousands of people who have developed various cancers after Zantac use.
Has Zantac Been Recalled by the FDA?
Yes, on April 1, 2020 the FDA issued a recall of Zantac due to NDMA in Zantac. While many Americans take ranitidine over-the-counter (OTC) for relief of heartburn and indigestion, prescription-strength ranitidine is sometimes used by physicians to treat and prevent ulcers in patients.
Although the FDA initially reported that NDMA levels (above 96 nanograms- well above the daily intake limit) in the contaminated ranitidine were barely any higher than the supposedly safe amounts found in common foods, it later declared the levels to be “unacceptably high.”
However, the agency is not currently recommending that patients stop taking ranitidine products immediately, but urging patients to speak to their doctors about alternative prescription and OTC medications for their conditions.
Meanwhile, several drug makers including Novartis-owned Sandoz Inc., Boehringer Ingelheim Apotex, Boehringer, and GlaxoSmithKline (the original developer of Zantac), announced a voluntary recall or halting distribution of some batches of their generic ranitidine-containing products in the U.S. and other countries.
It’s important to note that to date, brand-name Zantac (manufactured by Sanofi) was voluntarily recalled on October 18, 2019, as was the generic version, ranitidine when they discovered NDMA contamination levels that greatly exceeded the FDA's acceptable daily intake suggestions.
If you are concerned whether your particular brand of ranitidine is impacted by NDMA exposure, links to information about the specific products that have been recalled by their manufacturers are provided in the “Resources” section at the end of this article.
What are the Side Effects Associated With Zantac and NDMA?
The environmental contaminant NDMA has been known to cause serious, non-cancerous liver damage in humans and is used by cancer researchers to induce liver tumors in rodents. It is believed to be a risk factor for a range of human digestive system cancers including that of the stomach, colon, pancreas, and liver cancer as well as bladder cancer.
Cancer of the stomach (adenocarcinoma) is treatable when caught at an early stage. Recent tests show one of its precursors can be the condition known as GERD or acid reflux. It is also believed to be associated with obesity and smoking, as well as poor diet.
- Symptoms of stomach cancer include:
- Feeling bloated after eating
- Feeling full after eating small amounts of food
- Persistent heartburn
- Nausea or vomiting
- Stomach pain
- Weight loss
Medical treatment options for stomach cancer depend on the stage that the disease has progressed to, and include surgery (including removal of the stomach), radiation and chemotherapy.
Bladder cancer is fairly rare, accounting for just five percent of cancers diagnosed in the U.S. It is more likely to strike males over age 55 than females and is more common among Caucasians than other races.
Risk factors are believed to include family history, smoking, chronic bladder inflammation/infections, and exposure to certain industrial chemicals, including high levels of NDMA (n-nitrosodimethylamine). Like stomach cancer, bladder cancer is also highly treatable, with a reported five-year survival rate of over 75 percent.
However, if left untreated it can spread to vital organs including the lungs and liver via the lymph nodes.
Early symptoms of bladder cancer can mimic those of urinary tract infections and other ailments, and include: pain during urination, frequent need to urinate, difficulty urinating and blood in the urine.
Once the disease has progressed, symptoms can include: weight loss, fatigue, loss of appetite.
Bladder cancer is treated through surgical removal of cancerous tissue and even all or part of the bladder (cystectomy), chemotherapy, and radiation.
High levels of NDMA has also been linked to the following types of Zantac cancer:
- Esophageal cancer
- Pancreatic cancer
- Lung cancer
- Liver cancer
- Breast cancer
- Intestinal cancer
- Kidney cancer
- Lung cancer tumors
- Prostate cancer (in men under 65)
- Multiple myeloma
Should I Stop Taking Zantac?
If you are currently taking Zantac, you should contact your physician and discuss your situation with them. Your doctor can advise you of alternative medications and advise you how to proceed.
If you were taking over-the-counter Zantac or ranitidine, you may wish to review information on the recall from the U.S. Food and Drug Administration.
Have any Lawsuits Been Filed Against the Makers of Zantac?
The defendants are being sued by plaintiffs who took Zantac and other ranitidine products and either developed cancer or claim to be at risk for cancer.
The plaintiffs claim the drugmakers should have known of the potential risk for NDMA contamination and advised the medical community of the danger, in light of certain research that predated the FDA warning.
This research reportedly found that ranitidine can degrade into NDMA when combined with water during a chemical reaction.
Most of the current Zantac lawsuits claim the manufacturers 'failed to warn' consumers of the dangers of taking Zantac.
Whenever there is a flurry of new class action cases brought against specific defendants in different states, those early cases are often consolidated in a single state in what is known as a multi-district litigation (MDL), where they can all be heard in the same federal court before the same judge.
This is different from a class action lawsuit, and is done for efficiency in the pretrial hearing and motion process. A motion to have Zantac lawsuits centralized in an MDL has been filed and is pending in the U.S. District Court for the District of New Jersey.
The litigation is still in its early stages and there have been no settlements or verdicts related to Zantac injuries announced yet.
However, the Zantac lawsuits will seek compensation for each person's medical expenses, medical bills, lost wages and pain and suffering.
In the case where a family member has lost a loved one after taking Zantac, the families will be able to pursue a wrongful death claim.
What Compensation Can a Person Recover in a Zantac Cancer Lawsuit?
If you or a loved one has taken Zantac or ranitidine and developed stomach cancer or bladder cancer, contact the Zantac recall attorneys at Rosenfeld Injury Lawyers LLC at (888) 424-5757 to schedule a free consultation to discuss whether you have a valid claim for compensation from the drug companies involved.
The medication you are taking now could cause serious medical complications in the months or years ahead.
You could be eligible to receive financial compensation for all medical expenses associated with the health condition that resulted from your Zantac consumption, ongoing tests, lost income for the time your illness left you unable to work, pain and suffering, loss of normal life and other tangible and intangible damages.
Our law firm accepts all wrongful death lawsuits and defective drug injury claims through contingency fee agreements which postpone payment for our legal services until after we have successfully resolved your case.
If we are unable to secure compensation on your behalf through a trial award or negotiated out-of-court settlement, you owe us nothing. Let our experienced team of product liability and class action attorneys go to work for you and your family to fully compensate you for your Zantac cancer.
Have There Been Any Settlements of Zantac Cancer Lawsuits?
Many defective drug cases, such as Zantac, proceed through multi-district litigation for several years before settlement negotiations are considered.
How Long do I Have to File a Lawsuit for Cancer Related to Zantac or ranitidine products Use?
The time required to file a Zantac cancer lawsuit will be dependent on where you live and when you were diagnosed with cancer. Cases, such as Zantac lawsuits, are governed by a statute of limitations for filing a case.
Failure to comply with the applicable statute of limitations will bar a financial recovery. If you have questions about the statute of limitations for your situation, contact a Zantac cancer attorney at Rosenfeld Injury Lawyers.
Zantac Lawsuit Update: December, 2020If you have read through the material on this page, you are likely looking for information on pending Zantac lawsuits. On February 6, 2020 the United States Judicial Panel on Multidistrict Litigation transferred pending (and new) cases to Judge Robin L. Rosenberg in the Southern District of Florida. ((20-MD-2924)
Since that time, Judge Rosenberg has issued 56 pre-trial orders that address issues from discovery deadlines to deposition protocols.
Judge Rosenberg has also set deadlines for discovery materials to be produced by the manufacturers of Zantac and ranitidine to comply with requests made by plaintiff's.
Even in the Covid-19 era Judge Rosenberg continues to move the pending Zantac lawsuits forward in her docket.
While there is no trial date, our Zantac cancer attorneys will continue to update this webpage as new developments and rulings come forward in this litigation.
Do You or Your Family Member Develop Cancer After taking Zantac?
If you or a family member developed cancer after taking Zantac, you may qualify for a Zantac lawsuit pending against the manufacturers of these pharmaceutical drugs.
Rosenfeld Injury Lawyers is currently reviewing cases on behalf of individuals and families who have a loved one who developed cancer after taking Zantac / ranitidine.
Our law firm is reviewing each case individually, but here are some criteria that we are looking at when accepting cases.
Cancer Diagnosis: We are reviewing cases that may qualify to take part in the pending Zantac litigation involving: bladder cancer, breast cancer, colorectal cancer, esophageal cancer, kidney (renal) cancer, lung cancer, pancreatic cancer, prostate cancer, stomach cancer and liver cancer. We are looking at cancer diagnosis within 20 years of your last Zantac dosage.
Get a Free Consultation Today to Discuss Your Zantac Lawsuit. Get Legal Help From Trusted Zantac Cancer AttorneysRosenfeld Injury Lawyers LLC is committed to providing hands-on legal service for people who are dealing with cancer of the bladder, stomach, or colon after taking Zantac and ranitidine.
All of our prescription medication defect cases are handled on a contingency fee basis, where we only receive a legal fee when there is a successful recovery for you. We are headquartered in Chicago, Illinois, and handle cases across the United States.
This webpage is prepared and updated by attorney Jonathan Rosenfeld. Updated December 10, 2020. Rosenfeld Injury Lawyers LLC is also reviewing Valsartan cancer lawsuits, a blood pressure medication that has been recalled due to NDMA contamination and various cancers.